Norbert Ifrah Selected Research

Chromosome Aberrations (Chromosome Abnormalities)

1/2021

Lomustine is beneficial to older AML with ELN2017 adverse risk profile and intermediate karyotype: a FILO study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Norbert Ifrah Research Topics

Disease

42	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 08/2005
31	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2023 - 11/2004
18	Neoplasms (Cancer) 01/2023 - 12/2006
14	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 10/2023 - 04/2009
12	Philadelphia Chromosome 01/2018 - 02/2007
7	Leukemia 01/2020 - 07/2011
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018 - 01/2004
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 08/2020 - 05/2007
3	Thrombosis (Thrombus) 01/2020 - 10/2008
3	Lymphoma (Lymphomas) 01/2018 - 08/2002
3	Graft vs Host Disease (Graft-Versus-Host Disease) 02/2017 - 12/2006
3	Pathologic Complete Response 02/2017 - 10/2007
3	Ovarian Neoplasms (Ovarian Cancer) 07/2016 - 12/2007
3	Residual Neoplasm 03/2016 - 03/2013
2	Hemorrhage 01/2020 - 10/2008
2	Hypersensitivity (Allergy) 09/2016 - 09/2015
2	Hodgkin Disease (Hodgkin's Disease) 09/2013 - 11/2004
2	Thrombocytopenia (Thrombopenia) 02/2011 - 01/2004
2	Neutropenia 02/2011 - 01/2004
2	Acute Promyelocytic Leukemia 03/2010 - 02/2008
2	Hematologic Neoplasms (Hematological Malignancy) 01/2008 - 12/2006
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2021
1	T-Cell Leukemia (Leukemia, T Cell) 01/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 08/2020
1	Lactic Acidosis 01/2020
1	Venous Thromboembolism 01/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Rare Diseases (Rare Disease) 12/2017
1	Triploidy 10/2017
1	Aplastic Anemia (Anemia, Hypoplastic) 02/2017

Drug/Important Bio-Agent (IBA)

13	Cytarabine (Cytosar-U)FDA LinkGeneric 08/2020 - 01/2004
9	Asparaginase (Elspar)FDA Link 01/2020 - 10/2008
6	Core Binding Factors (Core-Binding Factor)IBA 12/2018 - 03/2013
5	Lomustine (CCNU)FDA Link 01/2021 - 10/2007
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2023 - 11/2013
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2009
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 04/2015
4	Dexamethasone (Maxidex)FDA LinkGeneric 08/2020 - 02/2007
4	Macrophage Colony-Stimulating FactorIBA 01/2020 - 12/2007
4	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 11/2018 - 10/2007
4	AnthracyclinesIBA 05/2017 - 11/2004
4	Imatinib Mesylate (Gleevec)FDA Link 11/2016 - 02/2007
4	Mitoxantrone (Novantrone)FDA LinkGeneric 04/2015 - 01/2004
4	TOR Serine-Threonine KinasesIBA 11/2013 - 01/2008
4	Phosphatidylinositols (Phosphatidylinositol)IBA 11/2010 - 08/2005
3	Gemtuzumab (Mylotarg)FDA Link 07/2021 - 11/2008
3	AntithrombinsIBA 01/2020 - 10/2008
3	Biomarkers (Surrogate Marker)IBA 09/2019 - 04/2009
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 04/2015
3	Methotrexate (Mexate)FDA LinkGeneric 02/2017 - 12/2006
3	Mechanistic Target of Rapamycin Complex 1IBA 11/2013 - 01/2008
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2008 - 06/2006
2	lipoarabinomannan (LAM)IBA 01/2021 - 11/2018
2	Azacitidine (5 Azacytidine)FDA Link 01/2021 - 04/2014
2	Rituximab (Mabthera)FDA Link 08/2020 - 09/2016
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 08/2020 - 06/2004
2	Fibrinogen (Factor I)FDA Link 01/2020 - 10/2008
2	CytokinesIBA 01/2020 - 07/2016
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2018 - 06/2015
2	Clofarabine (Clolar)FDA Link 04/2017 - 04/2015
2	Dasatinib (BMS 354825)FDA Link 11/2016 - 06/2015
2	Adrenal Cortex Hormones (Corticosteroids)IBA 08/2015 - 03/2014
2	Vincristine (Oncovin)FDA LinkGeneric 06/2015 - 02/2007
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2015 - 02/2011
2	Transcription Factors (Transcription Factor)IBA 06/2015 - 11/2010
2	Immunoglobulins (Immunoglobulin)IBA 06/2014 - 01/2006
2	Phosphotransferases (Kinase)IBA 11/2010 - 06/2006
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2010 - 02/2008
1	Mebendazole (Anti-Worm)FDA Link 01/2023
1	isocitrate dehydrogenase (NADP+)IBA 01/2021
1	DNA Methyltransferase 3AIBA 01/2021
1	Basic Helix-Loop-Helix Transcription FactorsIBA 01/2021
1	activin AIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 08/2020
1	ChemokinesIBA 01/2020
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2020
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Protein Tyrosine PhosphatasesIBA 01/2019
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2019
1	Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA 01/2019
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2018
1	AntibodiesIBA 01/2018
1	AsparagineIBA 01/2018
1	Cytokine Receptors (Cytokine Receptor)IBA 08/2017
1	Histones (Histone)IBA 08/2017
1	AndrogensIBA 02/2017
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 02/2017

Therapy/Procedure

38	Therapeutics 01/2023 - 08/2002
27	Drug Therapy (Chemotherapy) 07/2021 - 01/2004
12	Stem Cell Transplantation 01/2020 - 01/2004
8	Transplantation 12/2017 - 11/2004
5	Induction Chemotherapy 01/2017 - 10/2007
3	Hematopoietic Stem Cell Transplantation 01/2020 - 10/2015
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 09/2013 - 11/2004
2	Injections 11/2015 - 10/2008
1	Ligation 01/2020
1	Immunotherapy 01/2019
1	Homologous Transplantation 11/2018